Effects of icariin on erectile function and expression of nitric oxide synthase isoforms in castrated rats
Article first published online: 7 DEC 2005
Asian Journal of Andrology
Volume 7, Issue 4, pages 381–388, December 2005
How to Cite
Liu, W.-J., Xin, Z.-C., Xin, H., Yuan, Y.-M., Tian, L. and Guo, Y.-L. (2005), Effects of icariin on erectile function and expression of nitric oxide synthase isoforms in castrated rats. Asian Journal of Andrology, 7: 381–388. doi: 10.1111/j.1745-7262.2005.00066.x
- Issue published online: 7 DEC 2005
- Article first published online: 7 DEC 2005
- Received 2004-11-12 Accepted 2005-03-11
- corpus cavernosm;
- intracavernosal pressure;
- nitric oxide synthase;
- erectile dysfunction
Aim: To investigate the effect of icariin on erectile function and the expression of nitric oxide synthase (NOS) isoforms in castrated rats.
Methods: Thirty-two adult male Wistar rats were randomly divided into one sham-operated group (A) and three castrated groups (B, C and D). One week after surgery, rats were treated with normal saline (groups A and B) or oral icariin (1 mg/[kg·day] for group C and 5 mg/[kg·day] for group D) for 4 weeks. One week after treatment, the erectile function of the rats was assessed by measuring intracavernosal pressure (ICP) during electrostimulation of the cavernosal nerve. The serum testosterone (ST) levels, the percent of smooth muscle (PSM) in trabecular tissue, and the expression of mRNA and proteins of neuronal nitric oxide synthase (nNOS), inducible nitric oxide synthase (iNOS), endothelial nitric oxide synthase (eNOS) and phosphodiesterase V (PDE5) in corpus cavernosum (CC) were also evaluated.
Results: ICP, PSM, ST and the expression of nNOS, iNOS, eNOS and PDE5 were significantly decreased in group B compared with those in group A (P < 0.01). However, ICP, PSM and the expression of nNOS and iNOS were increased in groups C and D compared with those in group B (P < 0.05). Changes in ST and the expression of eNOS and PDE5 were not significant (P > 0.05) in groups C and D compared with those in group B.
Conclusion: Oral treatment with icariin (> 98.6 % purity) for 4 weeks potentially improves erectile function. This effect is correlated with an increase in PSM and the expression of certain NOS in the CC of castrated rats. These results suggest that icariin may have a therapeutic effect on erectile dysfunction.